SCHEMBL6970966

SCHEMBL6970966

COC(=O)C=Cc1ccc(C(=O)O)c(OC)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.68
FDPS P14324 1/20 0.63
ALDH1A1 P00352 6/20 0.58
KDM4E B2RXH2 5/20 0.58
SMN1; SMN2 Q16637 3/20 0.58
GAA P10253 2/20 0.58
MAPT P10636 2/20 0.58
HTT P42858 2/20 0.58
JAK2 O60674 1/20 0.58
HPGD P15428 4/20 0.56
HSD17B10 Q99714 4/20 0.56
MAPK1 P28482 3/20 0.56
APP P05067 2/20 0.56
ALOX15 P16050 2/20 0.56
TTR P02766 1/20 0.56
NFE2L2 Q16236 3/20 0.55
MEN1 O00255 3/20 0.54
TP53 P04637 3/20 0.54
CYP3A4 P08684 3/20 0.54
KMT2A Q03164 3/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6970963 1.00 EPHX2 (0.68) EPHX2FDPSALDH1A1KDM4ESMN1; SMN2
SCHEMBL3910758 0.88 KDM4E (0.73) ALDH1A1KDM4ESMN1; SMN2GAAHPGD
SCHEMBL3910762 0.88 KDM4E (0.73) ALDH1A1KDM4ESMN1; SMN2GAAHPGD
SCHEMBL3920819 0.86 ALDH1A1 (0.51) EPHX2FDPSALDH1A1KDM4ESMN1; SMN2
SCHEMBL3920813 0.86 ALDH1A1 (0.51) EPHX2FDPSALDH1A1KDM4ESMN1; SMN2
SCHEMBL28644547 0.86 MAOB (0.71) EPHX2FDPSALDH1A1KDM4ESMN1; SMN2
SCHEMBL28644543 0.86 MAOB (0.71) EPHX2FDPSALDH1A1KDM4ESMN1; SMN2
SCHEMBL6954731 0.85 EPHX2 (0.65) EPHX2FDPSALDH1A1KDM4ESMN1; SMN2
SCHEMBL6954729 0.85 EPHX2 (0.65) EPHX2FDPSALDH1A1KDM4ESMN1; SMN2
Methyl Cis-3,4-Dimethoxycinnamate SCHEMBL2411955 0.84 FDPS (0.80) EPHX2FDPSALDH1A1KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0879233-B1 CHINOLINE AND BENZIMIDAZOLE DERIVATIVES AS BRADYKININ AGONISTS FUJISAWA PHARMACEUTICAL CO (JP) 2003-08-13 EP disclosed
US-6194396-B1 ANTIALLERGENS; ANTIINFLAMMATION AGENTS; AUTOIMMUNE DISEASE; ANTISHOCK AGENTS; ANALGESICS; E.G., A 4 OR 7-PHENYLALKYLENE-OXYBENZIMIDAZOLE UNSUBSTITUTED OR SUBSTITUTED IN THE 1,2,3-POSITION WITH AN OXY, AMINO AND/OR THIO GROUP FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-02-27 US disclosed
US-6127389-A TREATMENT OF HYPERTENSION, RENAL DISEASES, HEART FAILURE, HYPERTENSION, MENIERE'S DISEASE, PERIPHERAL AND CEREBRAL CIRCULATORY DISORDERS, CLIMACTERIC DISTURBANCE, RETINOCHOROIDAL CIRCULATORY DISORDERS, MYOCARDIAL ISCHEMIA FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-10-03 US disclosed
US-6083961-A FOR PREVENTION AND/OR TREATMENT OF BRADYKININ OR ITS ANALOGUES MEDIATED DISEASES SUCH AS ALLERGY, INFLAMMATION, AUTOIMMUNE DISEASE, SHOCK, PAIN FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-07-04 US disclosed
US-6015818-A TREATING KIDNEY, BRAIN, AND CARDIOVASCULAR DISORDERS; HYPOTENSIVE AGENTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-01-18 US disclosed
EP-0879233-A1 CHINOLINE AND BENZIMIDAZOLE DERIVATIVES AS BRADYKININ AGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-25 EP disclosed
WO-1997028153-A1 CHINOLINE AND BENZIMIDAZOLE DERIVATIVES AS BRADYKININ AGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-08-07 WO disclosed
EP-0774462-A1 HETEROCYCLIC COMPOUND FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-05-21 EP disclosed